Core Insights - The cannabis industry is experiencing significant progress and innovation, despite many marijuana stocks underperforming [1] - The market is divided into two main areas: large multi-state operators (MSOs) and ancillary companies that provide services or products related to cannabis [2] - Ancillary marijuana companies are performing better due to their diversified business models, which help them withstand market fluctuations [3] Company Highlights - **Hydrofarm Holdings Group, Inc.**: Reports Q1 2025 earnings with net sales of $40.5 million, down from $54.2 million; gross profit decreased to $6.9 million with a gross profit margin of 17.0% [7] - **GrowGeneration Corp.**: Operates retail hydroponic and organic gardening stores; recently entered a distribution agreement with V1 Solutions to expand its market presence in the EU [8] - **High Tide Inc.**: Engages in cannabis retail across North America; recently opened two new Canna Cabana locations in Toronto and Winnipeg, indicating strong market performance in Manitoba and Ontario [11]

Thailand is reigning in the sale of cannabis without prescriptions. When the country liberalizes cannabis rules a few years ago, it was seen as a bold but controversial move in a region that has some of the most stringent drug laws in the world. For instance, I'm here in Singapore where trafficking certain amounts of drugs can carry the death penalty.This is estimated to be a billiondoll industry in Thailand. So, changing the rules could have major implications for people's livelihoods. When the rules were ...

Core Insights - A new study published by Tilray Medical focuses on the bioavailability of different cannabinoid formulations, specifically comparing Tilray's THC:CBD extract and nabiximols [1][4] Group 1: Study Overview - The study assessed pharmacokinetic parameters and relative bioavailability of two formulations: Tilray THC:CBD extract (10 mg/mL each of THC and CBD) and nabiximols (total dose of 10.8 mg THC and 10 mg CBD) [2] - Conducted with twelve healthy volunteers, the study revealed that the Cmax for THC and CBD was significantly higher for the Tilray extract compared to nabiximols [3] Group 2: Key Findings - The study found that THC and CBD were undetectable 24 hours post-dose, and 11-OH-THC was markedly reduced from its peak [3] - No serious adverse events were reported during the study, indicating a favorable safety profile for the Tilray formulation [3] Group 3: Implications and Future Directions - The findings suggest that the oral administration of Tilray's THC:CBD extract may achieve higher cannabinoid concentrations more quickly than nabiximols, which could have significant implications for therapeutic use [4] - Tilray's Medical Director emphasized the importance of understanding cannabinoid pharmacokinetics to enhance therapeutic outcomes [5]

Core Points - Glass House Brands Inc. held its annual and special meeting on June 20, 2025, where shareholders passed all resolutions presented [1] - All eight nominees for the Board of Directors were elected with overwhelming support, with voting percentages ranging from 99.350% to 99.999% [2] - Shareholders approved the re-appointment of Macias Gini & O'Connell LLP as auditors with a 99.99% favorable vote and a 97.85% approval for a one-time fixed increase to the rolling 10% share reserve under the long-term equity incentive plan [3] Company Overview - Glass House Brands is recognized as one of the fastest-growing, vertically integrated cannabis companies in the U.S., focusing on the California market [5] - The company emphasizes sustainable practices in its operations, which include greenhouse cultivation, manufacturing, brand-building, and retailing [5] - Glass House's brand portfolio includes Glass House Farms, PLUS Products, Allswell, and Mama Sue Wellness, along with a network of retail dispensaries [5]

TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX: TSNDF), a leading North American cannabis company, today announced the results of its annual meeting of shareholders held on June 24, 2025 (the "Meeting"). Common shareholders at the Meeting affirmatively approved the following resolutions: The re-election of Mr. Craig Collard, Ms. Ira Duarte, Mr. Ed Schutter, Ms. Kara DioGuardi and Mr. Jason Wild as directors of the Company for the ensuing year, ...

Core Points - Red White & Bloom Brands Inc. has rescheduled its Annual General Meeting (AGM) from June 27, 2025, to July 11, 2025, to allow for the completion and filing of its audited financial statements for the year ended December 31, 2024 [1] - The AGM will take place at the same time and location as previously indicated in the proxy materials sent to shareholders on May 28, 2025 [2] - Shareholders can cast their votes until 8:00 am Pacific Time on July 9, 2025, and no new proxy materials will be issued for the rescheduled AGM [3] Company Overview - Red White & Bloom Brands is a multi-jurisdictional cannabis operator with a focus on premium brands, operating in the United States, Canada, and internationally [4] - The company is primarily investing in major U.S. markets, including California, Florida, Missouri, Michigan, and Ohio, in addition to Canadian and international markets [4]

Group 1 - Cronos Group Inc. held its Annual Meeting of Shareholders on June 20, 2025, with 276,989,452 common shares voted, representing 71.87% of total outstanding shares [1] - All nominated directors were elected, each receiving over 92.3% of the votes in favor of their election, with specific percentages for each director ranging from 92.38% to 96.94% [2] - An advisory resolution on the compensation of named executive officers was approved with 94.13% of votes in favor, and Davidson & Company LLP was appointed as the independent auditor for fiscal year 2025 [2] Group 2 - Cronos is a global cannabinoid company focused on cannabis research, technology, and product development, aiming to build a strong brand portfolio including Spinach®, PEACE NATURALS®, and Lord Jones® [4]

Core Insights - Jushi Holdings Inc. has launched a new cannabis-infused wellness brand named Shayo in partnership with entrepreneur Stacey Rusch, targeting Virginia's medical cannabis market [1][3] - Shayo aims to provide a unique edible experience with products that emphasize joy and wellness, featuring two distinct rosin-infused fruit chews [2][3] Product Details - Shayo offers two products: Rise (Blood Orange Pomegranate) with a THC:CBG ratio of 1:2, and Rest (Berry Vanilla) with a THC:CBN ratio of 1:2, both designed for specific wellness outcomes [2] - The products are vegan, gluten-free, non-GMO, and made with natural fruit purées, highlighting their premium quality [2] Market Presence - Shayo products are currently available at all six Beyond Hello locations in Virginia, with plans for expansion to additional dispensaries across the state [3] - The early success of Shayo has exceeded expectations, indicating strong market reception [3] Company Background - Jushi Holdings Inc. is a vertically integrated cannabis company focused on building a multi-state portfolio of branded cannabis assets through acquisitions and competitive applications [6] - The company aims to maximize shareholder value while delivering high-quality products across the cannabis ecosystem [6]

Tilray Launches a Curated Selection of Canadian Cannabis Beverages, Vapes, and Pre-Rolls to Enrich Your Summer Activities TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, announces its 2025 summer cannabis collection offered by its wholly-owned licensed cannabis producers, Aphria Inc. and High Park Holdings Ltd. This curated roundup features bold ...

Core Viewpoint - AYR Wellness Inc. has entered into an Extended Agreement to extend the temporary waiver period related to its financial obligations, allowing for continued negotiations with senior lenders and exploration of strategic options to strengthen its capital structure [1][2][3] Group 1: Extended Agreement Details - The Extended Agreement extends the waiver period from June 19, 2025, to July 3, 2025 [1] - The waiver pertains to defaults related to the delay in filing interim financial statements for the quarter ended March 31, 2025, and specific payment defaults under other outstanding indebtedness [2] - This extension does not permanently waive existing defaults but facilitates ongoing dialogue to address financial obligations [3] Group 2: Company Overview - AYR Wellness is a leading vertically integrated U.S. multi-state cannabis operator with over 90 licensed dispensaries [5] - The company is committed to delivering high-quality cannabis products while positively impacting its team members and the communities it serves [5]